CSL's 2026 Impact Report

| Introduction | For Patients | For Science | For Society | Looking Ahead Bringing First Aid Education to More Communities CSL Seqirus has partnered with St John Ambulance in Queensland and New South Wales (NSW), Australia, to expand its First Aid in Schools program, providing education on bites and stings, with a focus on reaching regional, remote and First Nations communities. The partnership supports training, materials and travel to schools that often miss out on extracurricular programs. In Queensland, a 2025 pilot reached almost 500 students across four rural and remote schools, while further visits are extending into Far North Queensland and Cape York. In NSW, the program is building on a 2024–25 partnership that reached more than 10,000 students across 120 schools with bites and stings education, helping equip children with potentially lifesaving knowledge while improving access to first aid education. In 2026, CSL awarded eight Community Impact Awards to emerging leaders working across Australia’s health sector, in partnership with Melbourne Business School’s Centre for Social Purpose Organisations. The scholarships provide access to the three-month Emerging Social Purpose Leaders Program, equipping participants with practical skills in leadership, strategy, finance and stakeholder engagement. By investing in the people behind community health organisations, CSL is helping promising leaders strengthen their organisations and turn good ideas into lasting improvements in health. The 2026 recipients came from a range of organisations, including Murdoch Children’s Research Institute, Walter and Eliza Hall Institute of Medical Research (WEHI), UsherKids Australia, Hearing Australia, Patients Australia, The Fred Hollows Foundation and Rural Health Connect. Investing in the Next Generation of Health Leaders FY26 Sustainability Highlights CSL’s Healthier World strategy reflects the company’s commitment to improving lives, safeguarding public health and creating long-term shared value for patients, donors, employees, communities and the environment. In FY26, CSL continued to advance this strategy through its two core pillars – Healthier Communities and Healthier Environment – focusing on the areas where the company can have the greatest positive impact. Key improvements included: • Expanded access to lifesaving therapies through partnerships, including World Federation of Hemophilia (WFH) humanitarian aid support for people with bleeding disorders • Advanced FY30 access commitments, treating 1,993 people with bleeding disorders and supporting anaemia treatment for 207,000 people • Embedded patient insights into 100% of Phase II/III clinical trials, with flexible options to improve accessibility and reduce burden • Strengthened donor experience through a new framework and Voice of the Donor survey, achieving an 88.3% satisfaction score • Reduced Scope 1 and 2 Greenhouse Gas (GHG) emissions by 28% from the FY21 baseline • Sourced 100% of paper-based packaging used directly in manufacturing from certified sustainable forestry sources. 30 | CSL IMPACT REPORT 2026

RkJQdWJsaXNoZXIy MjE2NDg3